1-855-378-42281-855-378-4228
One of the outpatient rehab alternatives for individuals in Bainville struggling with opioid abuse and addiction is opioid maintenance therapy. Some facilities and doctors are certified to administer certain medications to opioid dependent people, many of which are opioids themselves and are habit forming. With low enough doses the individual doesn't experience being high and also doesn't experience acute cravings and isn't experiencing opioid withdrawal. Methadone is the first med used for this sole purpose, but there are alternative options currently to select from.
Methadone is an opioid and can be taken at an outpatient medical center licensed to administer the drug, which is taken daily in liquid or pill form. The cost of the drug is approximately under $200 per month. Buprenorphine is also an opioid-based drug, and is in pill form often taken one day on, one day off. But different from Methadone which is only be given in highly well-regulated medical centers, Buprenorphine can be and is prescribed and administered in doctor's offices. The cost monthly of buprenorphine is approximately just under $300 monthly for the generic version of the medication. There is also a type of buprenorphine that contains naloxone, that is a med which blocks the effects of opiates. Someone taking this version of the drug, AKA Suboxone, would find it more difficult to get high from opioids if they relapsed while taking the drug. It is also taken daily, and is priced approximately $450 a month. Naltrexone is another drug taken in opioid maintenance therapy, but unlike the other medications aforementioned it's an opiate blocker and isn't an opiate. There is an option to take this drug as a monthly shot, which is called Vivitrol. As an opioid blocker, the drug prevents an individual from experience being high from opioids, and therefore lowers the risk associated with relapse. This daily injection costs anywhere from $1000 to $1200 /month.
For All Drug and Alcohol Rehab Programs In Bainville, Click Here.
